166 related articles for article (PubMed ID: 14650291)
1. [Superficial grade G2 tumors of the bladder: recurrence, progression, prognosis].
Sebe P; Lebret T; Molinie V; Herve JM; Yonneau L; Lugagne PM; Saporta F; Orsoni JL; Butreau M; Botto H
Prog Urol; 2003 Sep; 13(4):608-12. PubMed ID: 14650291
[TBL] [Abstract][Full Text] [Related]
2. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
3. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
5. [Surveillance and prognosis of "T1" superficial tumors of the bladder. Homogeneous series of 88 cases followed for 1 to 22 years].
Lachand AT; Texier J; Texier P
Prog Urol; 2001 Jun; 11(3):472-7. PubMed ID: 11512460
[TBL] [Abstract][Full Text] [Related]
6. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
7. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
8. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
9. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of prognostic factors in superficial bladder tumors].
Páez Borda A; Martín Osés E; de la Cal López M; Llorente Abarca C; Berenguer Sánchez A
Arch Esp Urol; 1997 Mar; 50(2):121-6. PubMed ID: 9206936
[TBL] [Abstract][Full Text] [Related]
11. [Clinical course of superficial transitional carcinoma of the bladder without poor prognostic factors].
Arrizabalaga Moreno M; Castro Pita M; Díez Rodríguez JM; García González JI; Navarro Sebastián J; Extramiana Cameno J; Esteban Artiaga R; Paniagaa Andrés P
Actas Urol Esp; 1997 Mar; 21(3):187-94. PubMed ID: 9324883
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance and prognosis of "Ta" superficial tumors of the bladder. Homogeneous series of 138 cases followed for 1 to 18 years].
Lachand AT; Texier J; Texier P
Prog Urol; 2001 Jun; 11(3):466-71. PubMed ID: 11512459
[TBL] [Abstract][Full Text] [Related]
13. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of clinicopathologic factors in superficial bladder tumors: a retrospective analysis].
Rammeh-Rommani S; Zermani R; Zouari B; Sfaxi M; Chabchoub A; Farah F; Kourda N; Ayed M; Ben Jilani S
Tunis Med; 2005 Dec; 83(12):746-9. PubMed ID: 16450942
[TBL] [Abstract][Full Text] [Related]
15. [Initial conservative treatment for grade 3 Ta-1 superficial bladder cancer].
Fujimoto K; Chihara Y; Kondo H; Hirao Y
Hinyokika Kiyo; 2006 Jun; 52(6):433-8. PubMed ID: 16848356
[TBL] [Abstract][Full Text] [Related]
16. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
[TBL] [Abstract][Full Text] [Related]
17. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors of superficial bladder cancer recurring after initial transurethral resection].
Nakata S; Nakano K; Takahashi H; Shimizu K
Hinyokika Kiyo; 2005 Apr; 51(4):229-33. PubMed ID: 15912780
[TBL] [Abstract][Full Text] [Related]
19. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
[TBL] [Abstract][Full Text] [Related]
20. [PTa bladder tumours: prognostic factors of recurrence and progression].
Martinache G; Zerbib M; Descazeaud A; Debré B; Peyromaure M
Prog Urol; 2008 Jan; 18(1):35-40. PubMed ID: 18342154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
